Bank of New York Mellon Corp Lowers Holdings in Anterix Inc. (NASDAQ:ATEX)

Bank of New York Mellon Corp lowered its stake in Anterix Inc. (NASDAQ:ATEXFree Report) by 11.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 34,692 shares of the company’s stock after selling 4,306 shares during the quarter. Bank of New York Mellon Corp’s holdings in Anterix were worth $1,064,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in ATEX. FMR LLC lifted its stake in shares of Anterix by 76.4% in the 3rd quarter. FMR LLC now owns 250,955 shares of the company’s stock valued at $9,451,000 after purchasing an additional 108,683 shares during the last quarter. Jane Street Group LLC increased its stake in shares of Anterix by 78.2% during the third quarter. Jane Street Group LLC now owns 128,892 shares of the company’s stock valued at $4,854,000 after buying an additional 56,559 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of Anterix by 188.2% during the third quarter. JPMorgan Chase & Co. now owns 33,832 shares of the company’s stock valued at $1,274,000 after purchasing an additional 22,092 shares in the last quarter. Verition Fund Management LLC raised its position in shares of Anterix by 309.1% in the 3rd quarter. Verition Fund Management LLC now owns 22,199 shares of the company’s stock worth $836,000 after acquiring an additional 16,773 shares in the last quarter. Finally, Paloma Partners Management Co purchased a new position in Anterix in the third quarter valued at about $769,000. Hedge funds and other institutional investors own 87.67% of the company’s stock.

Anterix Stock Up 0.9 %

ATEX opened at $38.14 on Tuesday. The firm’s 50-day moving average price is $34.92 and its 200-day moving average price is $34.20. The company has a market cap of $708.91 million, a P/E ratio of -23.40 and a beta of 0.86. Anterix Inc. has a 52-week low of $27.37 and a 52-week high of $42.91.

Analyst Upgrades and Downgrades

Separately, JPMorgan Chase & Co. upped their price target on Anterix from $61.00 to $67.00 and gave the stock an “overweight” rating in a research report on Thursday, February 13th.

Check Out Our Latest Stock Analysis on ATEX

Anterix Company Profile

(Free Report)

Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.

Featured Articles

Want to see what other hedge funds are holding ATEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anterix Inc. (NASDAQ:ATEXFree Report).

Institutional Ownership by Quarter for Anterix (NASDAQ:ATEX)

Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.